Skip to main content

Drug Safety

Podcast microphone headphones
Day 1 (part one): ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Day 1 (part two): ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Podcast microphone headphones
Day 4: ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Day 3: ACR 2019 Podcast
RheumNow
Podcast microphone headphones
ACR Posters
ACR 2019 - Report from Day 3 (Tuesday)
Jack Cush, MD
Here's my summary of key studies presented Tuesday.  Tofacitinib in Polyarticular JIA Abstract L22. Dr. Hermine Brunner presented the results of a phase 3 trial of tofacitinib (Tofa) in children…
iv infusion hospital drip
Rheumatic immune-related adverse events can start at almost any time after the commencement after immune checkpoint inhibitor immunotherapy for cancer, and are liable to persist long after the…
vaccine shot
Herpes Zoster Vaccine Update
Cassandra Calabrese, DO
Shingrix (GSK), the herpes zoster subunit vaccine (a two-shot series), was approved by the FDA in Fall 2018 and is currently approved for use in adults 50 years and older. Shingrix has replaced the…
foot pain gout
Therapies targeting sUA accumulation or improving its excretion are widely used for treatment of symptoms and prevention of progression of gout for decades. Despite our best effort, there is still…
light bulb thought
ACR 2019 - Report from Day One (Sunday)
Jack Cush, MD
Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day…
A Focus on WOCBA (Women of Childbearing Age)
Maeve Gamble, MD
Many rheumatic diseases affect women of childbearing age. In the age of biologic therapy, women are achieving better disease activity and there are increasing numbers of women with rheumatic diseases…
xray spine
IL-17 inhibitors in non-radiographic axial SpA
Philip Robinson, MD
This meeting sees new data on using anti-IL-17 agents in non-radiographic axial SpA. Up until now these patients have only had TNF inhibitors available, so data about the efficacy of IL17 inhibitors…
Checkpoint inhibitors
Rheumatic Manifestations of Cancer Immunotherapies
Antoni Chan, MD, PhD
One area I am very interested to learn more about at #ACR19 are the rheumatic manifestations of cancer immunotherapies. In the last 5 years, there has been an expansion of the use of immune…
puzzle
I have been attending the ACR Review Course for more than a decade, and it seems every year it gets better and better. Contrary to what most people think, this is not a board review course; it is…
×